Income Statement
OS THERAPIES INC
OSTX
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY |
|---|---|---|
|
Revenue
|
- | - |
|
Cost of Revenue
|
- | - |
|
Gross Profit
|
- | - |
|
Operating Expenses
|
28.71 | 6.81 |
|
Research & Development
|
16.36 | 2.84 |
|
Selling, General & Administrative
|
12.34 | 3.97 |
|
Other Operating Expenses
|
- | - |
|
Operating Income
|
-28.71 | -6.81 |
|
Non-Operating Income
|
-0.05 | -2.07 |
|
Interest Income
|
0.00 | - |
|
Interest Expense
|
- | - |
|
Other Non-Op Income / Expense
|
- | - |
|
Income Before Tax
|
- | - |
|
Income Tax Expense
|
- | - |
|
Non-Controlling Interest
|
- | - |
|
Net Income
|
-28.75 | -8.88 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY |
|---|---|---|
|
Depreciation & Amortization
|
- | - |
|
EBITDA
|
-28.34 | -6.81 |
|
Earnings Per Share (Basic)
|
-0.98 | -0.88 |
|
Diluted EPS
|
-0.98 | -0.88 |
|
Weighted Average Shares
|
- | 12.38 |
|
Diluted Weighted Avg Shares
|
29.25 | - |
|
Comprehensive Income
|
- | - |